Actively Recruiting
Impact of Tixel Treatment on Symptoms and Signs in Patients With Dry Eye Disease
Led by Aston University · Updated on 2026-01-26
36
Participants Needed
1
Research Sites
97 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study will examine how a standard Tixel treatment versus a sham treatment for eye wrinkles affects the symptoms and signs of Dry Eye Disease.
CONDITIONS
Official Title
Impact of Tixel Treatment on Symptoms and Signs in Patients With Dry Eye Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Mild to moderate periorbital wrinkles
- Ocular Surface Disease Index (OSDI) score of at least 23
- Noninvasive tear film break up time (NIBUT) of 10 seconds or less
- No other eye, skin, or immune problems
- Willing and able to provide written informed consent
- Willing to participate in all study activities and follow instructions
You will not qualify if you...
- Pregnancy or breastfeeding
- Lesions in the periorbital area
- Acute severe blepharitis
- Acute conjunctivitis
- Use of eye drops within 2 hours before examination
- Other concurrent anterior eye diseases
- Recent outdoors or sunbed tanning in the last 4 weeks
- Unwillingness to follow Tixel aftercare instructions after treatments
- Active or history of Herpes Simplex in the periorbital area
- Current skin cancer, malignant or advanced premalignant lesions or moles in the treatment area
- Impaired immune system or use of immunosuppressive medication
- Collagen disorders, keloid formation, or abnormal wound healing
- Previous invasive or ablative procedures in the treatment areas within 3 months prior or planned during treatment
- Use of medications, herbal treatments, supplements, or vitamins causing fragile skin or impaired healing within last 3 months
- Use of oral Isotretinoin within 3 months prior to treatment
- History of bleeding disorders or use of anticoagulants
- Tattoos or permanent makeup in the treated area
- Burned, blistered, irritated, or sensitive skin in the treated areas
- Thread lifting of the treatment area within last 3 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Vision Science, School of Optometry
Birmingham, United Kingdom, B4 7ET
Actively Recruiting
Research Team
S
Sunil Shah, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here